Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.1
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Beginning balance at Nov. 30, 2020 $ (2,665,135) $ 136,336 $ 36,581,600 $ (20,563,357) $ (18,819,714)
Beginning balance, shares at Nov. 30, 2020   13,633,638      
Exercise of stock options 191,622 $ 253 191,369    
Exercise of stock options, shares   25,300      
Compensatory element of stock options 84,818   84,818    
Net income 693,590       693,590
Ending balance at Feb. 28, 2021 (1,695,105) $ 136,589 36,857,787 (20,563,357) (18,126,124)
Ending balance, shares at Feb. 28, 2021   13,658,938      
Beginning balance at Nov. 30, 2021 4,184,314 $ 146,658 41,586,583 (20,812,734) (16,736,193)
Beginning balance, shares at Nov. 30, 2021   14,665,772      
Exercise of stock options 32,000 $ 100 31,900    
Exercise of stock options, shares   10,000      
Compensatory element of stock options 31,896   31,896    
Treasury stock (828,980)     (828,980)  
Net income 832,047       832,047
Ending balance at Feb. 28, 2022 $ 4,251,277 $ 146,758 $ 41,650,379 $ (21,641,714) $ (15,904,146)
Ending balance, shares at Feb. 28, 2022   14,675,772